RPN2 and breast cancer: However, glioma, breast cancer, and head and neck cancer cells with stem cell characteristics were reported to have decreased proteasome activity and reduced levels of the Rpn2 subunit of the 19S regulator but exhibited increased self-renewal capacity and tumorigenicity (161, 162).